These final results, together with a previous report showing that a small-molecule ACKR3 agonist CCX771 reveals anxiolytic-like conduct in mice,2 assist the thought of concentrating on ACKR3 as a unique solution to modulate the opioid process, which could open new therapeutic avenues for opioid-relevant Issues. Depending on available science https://janes517fvl1.59bloggers.com/profile